In March 2025, the company introduced new options for just a direct-to-buyer offering of its Wegovy weight loss drug. The company set up a new pharmacy, known as NovoCare, which would cost shoppers $499 every month for usage of the drug, a lot less than 50 percent the price of the drug by way of other pharmaceutical distribution networks.[53]inflam